Asymmetric Michael Addition in Synthesis of β-Substituted GABA Derivatives
dc.contributor.author | Han, Jianlin | |
dc.contributor.author | Escorihuela, Jorge | |
dc.contributor.author | Fustero, Santos | |
dc.contributor.author | Landa Alvarez, Aitor | |
dc.contributor.author | Soloshonok, Vadym Anatolievch | |
dc.contributor.author | Sorochinsky, Alexander | |
dc.date.accessioned | 2022-08-09T08:44:57Z | |
dc.date.available | 2022-08-09T08:44:57Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Molecules 27(12) : (2022) // Article ID 3797 | es_ES |
dc.identifier.issn | 1420-3049 | |
dc.identifier.uri | http://hdl.handle.net/10810/57260 | |
dc.description.abstract | γ-Aminobutyric acid (GABA) represents one of the most prolific structural units widely used in the design of modern pharmaceuticals. For example, β-substituted GABA derivatives are found in numerous neurological drugs, such as baclofen, phenibut, tolibut, pregabalin, phenylpiracetam, brivaracetam, and rolipram, to mention just a few. In this review, we critically discuss the literature data reported on the preparation of substituted GABA derivatives using the Michael addition reaction as a key synthetic transformation. Special attention is paid to asymmetric methods featuring synthetically useful stereochemical outcomes and operational simplicity. | es_ES |
dc.description.sponsorship | This research was funded by the National Natural Science Foundation of China (No. 21761132021), and IKERBASQUE, Basque Foundation for Science. The financial support from the University of the Basque Country UPV/EHU (UFIQOSYC11/22), Basque Government (GVgrant IT1236-19), and Ministerio de Ciencia e Innovación (grant PID2019-109633GBC21) for. A.L. are also acknowledged. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | MDPI | es_ES |
dc.relation | info:eu-repo/grantAgreement/MICINN/PID2019-109633GBC21 | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | pharmaceuticals | es_ES |
dc.subject | neurological drugs | es_ES |
dc.subject | γ-aminobutyric-acid derivatives | es_ES |
dc.subject | asymmetric Michael addition | es_ES |
dc.subject | chiral auxiliaries | es_ES |
dc.subject | enantioselective organocatalysis | es_ES |
dc.title | Asymmetric Michael Addition in Synthesis of β-Substituted GABA Derivatives | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.date.updated | 2022-06-23T12:22:15Z | |
dc.rights.holder | © 2022 by the authors.Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). | es_ES |
dc.relation.publisherversion | https://www.mdpi.com/1420-3049/27/12/3797 | es_ES |
dc.identifier.doi | 10.3390/molecules27123797 | |
dc.departamentoes | Química orgánica I | |
dc.departamentoeu | Kimika organikoa I |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as © 2022 by the authors.Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).